Elektrofi

Elektrofi is a biotechnology company dedicated to improving the management of various drugs, including monoclonal antibodies, therapeutic proteins, and other large-molecule drugs. Its breakthrough formulation platform enables stable, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies administered intravenously and enhance injectable products by reducing dosage volume and frequency. Elektrofi collaborates with pharmaceutical companies to co-develop patient-friendly delivery solutions.